Amgen’s Next Opponents
As worries for its anemia drugs abate, investors will start to worry about Merck and Novartis.
Permalink Comments off
Archive for October, 2007
Booster Shot
A new golden age of vaccines is at hand, promising inoculations against malaria, meningitis and much more.
Permalink Comments off
Do Staph Bacteria Kill More People Than HIV?
And if it does, why aren't drug companies doing better at developing weapons against it?
Permalink Comments off
Should Pfizer Buy Biogen? No.
It wouldn't be good for either company. Here's why.
Permalink Comments off
Fighting Malaria
Big Pharma's battle against malaria suddenly goes into overdrive.
Permalink Comments off